Fulminant blood sugar increase - a rare but life-threatening course (PubMed, Praxis (Bern 1994)) - Sep 9, 2026 - "A 71-year-old patient with known metastatic melanoma undergoing treatment with the immune checkpoint inhibitors Ipilimumab/Nivolumab presented with a rapid deterioration in general condition over the past 24 hours. We hereby diagnosed fulminant ICI- associated type 1 diabetes mellitus. Symptoms improved under insulin therapy."
Journal • Diabetes • Endocrine Disorders • Melanoma • Metabolic Disorders • Oncology • Solid Tumor • Type 1 Diabetes Mellitus
|
|
Moritz Sigg; Stefan Bilz; Stefan Diem
|